Emmes Publications | Emmes

Search

Show only items where

Author

Type

Term

Year

Keyword

Found 8 results

Author Title Type [ Year

]

Filters: First Letter Of Title is C and Author is Wolff, M [Clear All Filters]

2014

Kotloff, K. L., Halasa, N. B., Harrison, C. J., Englund, J. A., Walter, E. B., King, J. C., et al.. (2014). Clinical and Immune Responses to Inactivated Influenza A(H1N1)pdm09 Vaccine in Children. Pediatr Infect Dis J, 33, 865-871. presented at the 08/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25222307

2011

Frenck, Jr, R. W., Belshe, R., Brady, R. C., Winokur, P. L., Campbell, J. D., Treanor, J., et al.. (2011). Comparison of the Immunogenicity and Safety of a Split-Virion, Inactivated, Trivalent Influenza Vaccine (Fluzone®) Administered by Intradermal and Intramuscular Route in Healthy Adults. Vaccine, 29, 5666-5674. presented at the 08/2011. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21699951

2000

King, J. C., Treanor, J., Fast, P. E., Wolff, M., Yan, L., Iacuzio, D., et al.. (2000). Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults. J Infect Dis, 181(2), 725-8. presented at the 2000 Feb. doi:10.1086/315246

Belshe, B. R., Gruber, W. C., Mendelman, P. M., Mehta, H. B., Cho, I., Mahmood, K., et al.. (2000). Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infec Dis, 181, 11133-7. presented at the 2000.

Belshe, R. B., Gruber, W. C., Mendelman, P. M., Mehta, H. B., Mahmood, K., Reisinger, K., et al.. (2000). Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infect Dis, 181(3), 1133-7. presented at the 2000 Mar. doi:10.1086/315323

1999

Evans, T. G., Keefer, M. C., Weinhold, K. J., Wolff, M., Montefiori, D., Gorse, G. J., et al.. (1999). A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with Rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers. J Infec Dis, 180, 290-8. presented at the 1999.

Evans, T. G., Keefer, M. C., Weinhold, K. J., Wolff, M., Montefiori, D., Gorse, G. J., et al.. (1999). A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers. J Infect Dis, 180(2), 290-8. presented at the 1999 Aug. doi:10.1086/314895

Wolff, M., Moulton, L. H., Newcomer, W., Reid, R., & Santo, S. M.. (1999). A case-control-study of risk factors for homophiles influenza Type B disease in Navajo children. AM J Trop Med Hug, 60, 263-6. presented at the 1999.